Cannabimimetic fatty acid derivatives in cancer and inflammation.
about
Endocannabinoids as Guardians of MetastasisCannabinoids as therapeutic agents in cancer: current status and future implicationsMolecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamideAdelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats.Cannabinoid receptor systems: therapeutic targets for tumour intervention.A conformational transition in the adenylyl cyclase catalytic site yields different binding modes for ribosyl-modified and unmodified nucleotide inhibitorsMolecular Targets of Cannabidiol in Neurological DisordersProstaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity.Impaired turnover of prolactin receptor contributes to transformation of human breast cells.New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds.Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamideThe cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells.Chemical determinants involved in anandamide-induced inhibition of T-type calcium channels.Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone.Anti-inflammatory effect of palmitoylethanolamide on human adipocytes.Anti-cancer Activity of Natural and Synthetic Capsaicin Analogs.
P2860
Q26766163-EC761770-BC68-43BD-9461-322BB5372A9FQ26866298-3776B40B-9819-45A2-B1C7-26B8733D35FAQ28362078-58B105A8-B0AF-48B3-AB9D-DBFED55BF314Q34772868-E50F73F4-667F-49E0-904B-48EAB5CC286FQ35593944-E9B1B8F0-528C-4086-9F70-02C83B627E2BQ36066091-2B1B73C6-E960-4857-91A7-8749991D1D62Q36157649-F18C7C4A-E0D5-4C78-B6E6-C95FFD62559DQ36734402-97923E28-ADD7-47D2-A63B-E758B81B677DQ37149031-DFDE66A0-8986-4D80-81F0-633C73AE307DQ38395251-6D6C31A0-3298-427E-BBC3-5BFF9047214AQ39256299-86CCF39B-CC37-42CE-B4F1-332BD56233DEQ39775715-1FD8934B-6044-496C-8236-1D1784EDB2BEQ40205455-887CB0A5-7C85-4C23-86B8-A1B023717517Q42379739-BA2F51C6-E21B-44E3-93B1-FF7F5ADCCEFBQ44177463-FF76F518-87CD-46E8-AFAE-A02472A4C966Q46170516-EDAE5E42-C9A9-4C43-9AE7-B330926C7E6EQ47778782-970C1502-5C6E-454C-82D3-FC81E6BD4079
P2860
Cannabimimetic fatty acid derivatives in cancer and inflammation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cannabimimetic fatty acid derivatives in cancer and inflammation.
@ast
Cannabimimetic fatty acid derivatives in cancer and inflammation.
@en
type
label
Cannabimimetic fatty acid derivatives in cancer and inflammation.
@ast
Cannabimimetic fatty acid derivatives in cancer and inflammation.
@en
prefLabel
Cannabimimetic fatty acid derivatives in cancer and inflammation.
@ast
Cannabimimetic fatty acid derivatives in cancer and inflammation.
@en
P2093
P1476
Cannabimimetic fatty acid derivatives in cancer and inflammation.
@en
P2093
L De Petrocellis
V Di Marzo
P356
10.1016/S0090-6980(00)00054-X
P577
2000-04-01T00:00:00Z